Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

248 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low rate of infusional toxicity after expanded cord blood transplantation.
Bear AS, Hanley PJ, Bosque DM, Cruz CR, Kaur I, Liu H, Kebriaei P, Hosing C, Rezvani K, Oran B, De Lima MJ, Bollard CM, Shpall EJ. Bear AS, et al. Among authors: oran b. Cytotherapy. 2014 Aug;16(8):1153-7. doi: 10.1016/j.jcyt.2013.12.011. Epub 2014 Feb 28. Cytotherapy. 2014. PMID: 24582458 Free PMC article.
Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan.
Oran B, Giralt S, Saliba R, Hosing C, Popat U, Khouri I, Couriel D, Qazilbash M, Anderlini P, Kebriaei P, Ghosh S, Carrasco-Yalan A, de Meis E, Anagnostopoulos A, Donato M, Champlin RE, de Lima M. Oran B, et al. Biol Blood Marrow Transplant. 2007 Apr;13(4):454-62. doi: 10.1016/j.bbmt.2006.11.024. Epub 2007 Feb 8. Biol Blood Marrow Transplant. 2007. PMID: 17382251 Free PMC article. Clinical Trial.
Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment.
Oran B, Donato M, Aleman A, Hosing C, Korbling M, Detry MA, Wei C, Anderlini P, Popat U, Shpall E, Giralt S, Champlin RE. Oran B, et al. Biol Blood Marrow Transplant. 2007 Apr;13(4):469-77. doi: 10.1016/j.bbmt.2006.11.020. Epub 2007 Feb 8. Biol Blood Marrow Transplant. 2007. PMID: 17382253 Free article.
Leukemia burden delays lymphocyte and platelet recovery after allo-SCT for AML.
Saliba RM, Komanduri KV, Giralt S, de Souza J, Patah P, Oran B, Couriel D, Rondon G, Champlin RE, de Lima M. Saliba RM, et al. Among authors: oran b. Bone Marrow Transplant. 2009 May;43(9):685-92. doi: 10.1038/bmt.2008.376. Epub 2008 Nov 17. Bone Marrow Transplant. 2009. PMID: 19011667 Free PMC article. Clinical Trial.
Significance of persistent cytogenetic abnormalities on myeloablative allogeneic stem cell transplantation in first complete remission.
Oran B, Popat U, Rondon G, Ravandi F, Garcia-Manero G, Abruzzo L, Andersson BS, Bashir Q, Chen J, Kebriaei P, Khouri IF, Koca E, Qazilbash MH, Champlin R, de Lima M. Oran B, et al. Biol Blood Marrow Transplant. 2013 Feb;19(2):214-20. doi: 10.1016/j.bbmt.2012.09.002. Epub 2012 Sep 13. Biol Blood Marrow Transplant. 2013. PMID: 22982533 Free PMC article.
248 results